How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Kingsbury, Sarah R ^a   Hensor, Elizabeth M A ^a   Walsh, Ceara A E ^a   Hochberg, Marc C ^b   Conaghan, Philip G ^a  

^a Chapel Allerton Hospital   (United Kingdom)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

knee osteoarthritis; Medications; Osteoarthritis Initiative

Indexed keywords

ANALGESIC AGENT; CHONDROITIN; CYCLOOXYGENASE 2 INHIBITOR; DIMETHYL SULFONE; DOXYCYCLINE; ESOMEPRAZOLE; GLUCOSAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; OMEPRAZOLE; OPIATE DERIVATIVE; PARACETAMOL; PROTON PUMP INHIBITOR; S ADENOSYLMETHIONINE; STEROID;

ADULT; AGED; ARTHRALGIA; ARTICLE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HUMAN; KELLGREN LAWRENCE GRADE; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NATIONAL INSTITUTES OF HEALTH OSTEOARTHRITIS INITIATIVE; PRESCRIPTION; RATING SCALE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SYMPTOM; TREATMENT DURATION; UNITED STATES; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; FACTUAL DATABASE; KNEE; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS; TIME;

ACETAMINOPHEN; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; LOGISTIC MODELS; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); OSTEOARTHRITIS, KNEE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84883270417     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4286     Document Type: Article

References (40)

1. Keenan AM, McKenna SP, Doward LC, Conaghan PG, Emery P, Tennant A. Development and validation of a needs-based quality of life instrument for osteoarthritis. Arthritis Rheum 2008, 59:841-848.
2. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003, 290:2443-2454.
3. Yelin E, Sonneborn D, Trupin L. The prevalence and impact of accommodations on the employment of persons 51-61 years of age with musculoskeletal conditions. Arthritis Care Res 2000, 13:168-176.
4. Arthritis Care; OANation 2012, , http://www.arthritiscare.org.uk/LivingwithArthritis/oanation-2012
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
6. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35.
7. Leigh JP, Seavey W, Leistikow B. Estimating the costs of job related arthritis. J Rheumatol 2001, 28:1647-1654.
8. Allen KD, Helmick CG, Schwartz TA, DeVellis RF, Renner JB, Jordan JM. Racial differences in self-reported pain and function among individuals with radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 2009, 17:1132-1136.
9. Allen KD, Oddone EZ, Coffman CJ, Keefe FJ, Lindquist JH, Bosworth HB. Racial differences in osteoarthritis pain and function: potential explanatory factors. Osteoarthritis Cartilage 2010, 18:160-167.
10. Stubbs D, Krebs E, Bair M, Damush T, Wu J, Sutherland J, Kroenke K. Sex Differences in pain and pain-related disability among primary care patients with chronic musculoskeletal pain. Pain Med 2010, 11:232-239.
11. Dominick KL, Baker TA. Racial and ethnic differences in osteoarthritis: prevalence, outcomes, and medical care. Ethn Dis 2004, 14:558-566.
12. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010, 18:476-499.
13. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905-1915.
14. Conaghan PG, Dickson J, Grant RL. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 2008, 336:502-503.
15. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012, 64:455-474.
16. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, Lohmander S, Leeb B, Lequesne M, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Serni U, Swoboda B, Verbruggen G, Zimmerman-Gorska I, Dougados M. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003, 62:1145-1155.
17. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005, 165:281-286.
18. Dominick KL, Ahern FM, Gold CH, Heller DA. Gender differences in NSAID use among older adults with osteoarthritis. Ann Pharmacother 2003, 37:1566-1571.
19. Dominick KL, Dudley TK, Grambow SC, Oddone EZ, Bosworth HB. Racial differences in health care utilization among patients with osteoarthritis. J Rheumatol 2003, 30:2201-2206.
20. Dominick KL, Bosworth HB, Jeffreys AS, Grambow SC, Oddone EZ, Horner RD. Racial/ethnic variations in non-steroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis. Pharmacoepidemiol Drug Saf 2004, 13:683-694.
21. Dominick KL, Bosworth HB, Dudley TK, Waters SJ, Campbell LC, Keefe FJ. Patterns of opioid analgesic prescription among patients with osteoarthritis. J Pain Palliat Care Pharmacother 2004, 18:31-46.
22. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002, 287:337-344.
23. Masso Gonzalez EL, Patrignani P, Tacconelli S, Garcia Rodriguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum 2010, 62:1592-1601.
24. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006, 296:1633-1644.
25. Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbol EL, Sorensen R, Folke F, Buch P, Gadsboll N, Rasmussen S, Poulsen HE, Kober L, Madsen M, Torp-Pedersen C. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009, 169:141-149.
26. Fosbol EL, Gislason GH, Jacobsen S, Folke F, Hansen ML, Schramm TK, Sorensen R, Rasmussen JN, Andersen SS, Abildstrom SZ, Traerup J, Poulsen HE, Rasmussen S, Kober L, Torp-Pedersen C. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009, 85:190-197.
27. Lanas A, Tornero J, Zamorano JL. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study. Ann Rheum Dis 2010, 69:1453-1458.
28. Osteoarthritis Initiative.
29. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
30. Paradowski PT, Englund M, Lohmander LS, Roos EM. The effect of patient characteristics on variability in pain and function over two years in early knee osteoarthritis. Health Qual Life Outcomes 2005, 3:59.
31. Neogi T, Nevitt MC, Yang M, Curtis JR, Torner J, Felson DT. Consistency of knee pain: correlates and association with function. Osteoarthritis Cartilage 2010, 18:1250-1255.
32. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Gray R, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990, 33:1601-1610.
33. Gore M, Sadosky A, Leslie D, Tai KS, Seleznick M. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther 2011, 33:1914-1931.
34. Scholes D, Stergachis A, Penna PM, Normand EH, Hansten PD. Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis. J Rheumatol 1995, 22:708-712.
35. Zhao SZ, Wentworth C, Burke TA, Makuch RW. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiol Drug Saf 2004, 13:277-287.
36. Berger A, Bozic K, Stacey B, Edelsberg J, Sadosky A, Oster G. Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum 2011, 63:2268-2275.
37. Report of the American College of Rheumatology Pain Management Task Force. Arthritis Care Res 2010, 62:590-599.
38. Sun SX, Lee KY, Bertram CT, Goldstein JL. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Curr Med Res Opin 2007, 23:1859-1866.
39. Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009, 104:728-738.
40. American Geriatric Society Clinical Practice Guideline: Pharmacological Management of Persistent Pain in Older Persons. J Am Ger Soc 2009, 57:1331-1346.